z-logo
open-access-imgOpen Access
Cellular Therapy with Donor Mesenchymal Stem Cells Combined with Co-Stimulation Blockade Prolongs Solid Organ Allograft Survival.
Author(s) -
Abraham J. Matar,
Brendan P. Lovasik,
Steven C. Kim,
Cynthia Breeden,
David A. Faber,
Andrew Adams
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.454
Subject(s) - medicine , mesenchymal stem cell , transplantation , mixed lymphocyte reaction , cd90 , immunology , stem cell , cancer research , cd34 , pharmacology , t cell , immune system , pathology , biology , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom